Validation of reverse sequence screening for syphilis

Journal of Clinical Microbiology

Volumn 50, Issue 4, 2012, Pages 1501-

  Lipinsky, Dafna ^a   Schreiber, Licita ^a   Kopel, Vered ^a   Shainberg, Bracha ^a  

^a Central Laboratory   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

AGGLUTINATION TEST; ALGORITHM; CHEMOLUMINESCENCE; FALSE POSITIVE RESULT; HUMAN; IMMUNOASSAY; LETTER; MAJOR CLINICAL STUDY; NONHUMAN; PREVALENCE; PRIORITY JOURNAL; SCREENING TEST; SEROLOGY; SYPHILIS; TREPONEMA PALLIDUM; TREPONEMA PALLIDUM PARTICLE AGGLUTINATION TEST; VALIDITY;

FALSE POSITIVE REACTIONS; HUMANS; INCIDENCE; RETROSPECTIVE STUDIES; SYPHILIS; SYPHILIS SERODIAGNOSIS;

EID: 84858609342     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.06286-11     Document Type: Letter

References (4)

1. CDC. 2010. Sexually transmitted disease treatment guidelines. MMWR Morb. Mortal. Wkly. Rep. 59:1-110.
2. CDC. 2011. Discordant results from reverse sequence syphilis screening-five laboratories, United States, 2006-2010. MMWR Morb. Mortal. Wkly. Rep. 60:133-137.
3. Marangoni A, Moroni A, Accardo S, Cevenini R. 2009. Diagnosis of syphilis with automated immunoassays. J. Clin. Lab. Anal. 23:1-6.
4. Young H, Pryde J, Duncan L, Dave J. 2009. The architect syphilis assay for antibodies to Treponema pallidum: an automated screening assay with high sensitivity in primary syphilis. Sex. Transm. Infect. 85:19-23.